Researchers Question Value of Confirmatory Trials Under Accelerated Approval

Sponsors seeking accelerated approval from the FDA should know that a required postapproval confirmatory trial takes about seven months longer than the typical phase 3 trial, leading some researchers to suggest that accelerated approval doesn’t give a drugmaker as much advantage as it appears.
Source: Drug Industry Daily